| Author |
Title |
Year |
Publication |
Volume |
Pages |
| Batista, K.M.P.; Eulate-Beramendi, S.A. de; Pina, K.Y.A.R. de; Figueira, P.R.; Canal, A.F.; Chasin, J.M.A.; Meilan, A.; Ugalde, R.; Vega, I.F. |
Mesenchymal/proangiogenic factor YKL-40 related to glioblastomas and its relationship with the subventricular zone |
2017 |
Folia Neuropathologica |
55 |
14-22 |
| Khalifa, J.; Tensaouti, F.; Lusque, A.; Plas, B.; Lotterie, J.-A.; Benouaich-Amiel, A.; Uro-Coste, E.; Lubrano, V.; Cohen-Jonathan Moyal, E. |
Subventricular zones: new key targets for glioblastoma treatment |
2017 |
Radiation Oncology (London, England) |
12 |
67 |
| Brodie, S.; Lee, H.K.; Jiang, W.; Cazacu, S.; Xiang, C.; Poisson, L.M.; Datta, I.; Kalkanis, S.; Ginsberg, D.; Brodie, C. |
The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells |
2017 |
Oncotarget |
8 |
31785-31801 |
| Sullivan, K.E.; Rojas, K.; Cerione, R.A.; Nakano, I.; Wilson, K.F. |
The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells |
2017 |
Oncotarget |
8 |
22325-22343 |
| Glaser, T.; Han, I.; Wu, L.; Zeng, X. |
Targeted Nanotechnology in Glioblastoma Multiforme |
2017 |
Frontiers in Pharmacology |
8 |
166 |
